This invention describes a system for managing diabetes. It uses an app on a smartphone or similar device to guide a user through an initial glucose testing schedule. The app then takes these glucose results, and optionally the user's exercise and food intake data, to create a personalized health profile. It's important to note that while the abstract describes a complex microneedle device, the actual claims focus on this software-based method for diabetes management.
Why it matters: Filed before widespread continuous glucose monitors (CGMs) and advanced AI for health data. Today, CGMs provide continuous data streams, and AI can generate far more dynamic and insightful user profiles from glucose, exercise, and food data than was feasible in 2017.
AI gives you a few directions you could take this. Pick one, and we check whether your version is different enough to patent, then write the filing.
Reinvent this with AI